Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Ficorella, Corrado"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-7 z 7
    Tytuł:
    Host immune-inflammatory markers to unravel the heterogeneous outcome and assessment of patients with PD-L1 ≥50% metastatic non-small cell lung cancer and poor performance status receiving first-line immunotherapy.
    Autorzy:
    Banna GL; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy.
    Tiseo M; Department of Medicine and Surgery, University of Parma, Parma, Italy.; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.
    Cortinovis DL; Medical Oncology Unit, ASST San Gerardo Hospital Monza, Monza, Italy.
    Facchinetti F; Université Paris-Saclay, Institut Gustave Roussy, Inserm, Biomarqueurs Prédictifs et Nouvelles Stratégies Thérapeutiques en Oncologie, Villejuif, France.
    Aerts JGJV; Department of Pulmonary Diseases, Erasmus Medical Center, Rotterdam, the Netherlands.
    Baldessari C; Dipartimento di Oncologia ed Ematologia, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.
    Giusti R; Medical Oncolgy, St. Andrea Hospital, Rome, Italy.
    Bria E; Comprehensive Cancer Center, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Rome, Italy.; Department of Translational Medicine and Surgery, Università Cattolica del Sacro Cuore, Rome, Italy.
    Grossi F; Division of Medical Oncology, University of Insubria, Varese, Italy.
    Berardi R; Oncology Clinic, Università Politecnica Delle Marche, Ospedali Riuniti Di Ancona, Ancona, Italy.
    Morabito A; Thoracic Medical Oncology, Istituto Nazionale Tumori 'Fondazione G Pascale', IRCCS, Naples, Italy.
    Catino A; Thoracic Oncology Unit, Clinical Cancer Center IRCCS Istituto Tumori 'Giovanni Paolo II', Bari, Italy.
    Genova C; Lung Cancer Unit; IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
    Mazzoni F; Department of Oncology, Careggi University Hospital, Florence, Italy.
    Gelibter A; Medical Oncology (B), Policlinico Umberto I, 'Sapienza' University of Rome, Rome, Italy.
    Rastelli F; UOC Oncologia Ascoli Piceno - San Benedetto del Tronto, Ancona, Italy.
    Macerelli M; Department of Oncology, University Hospital Santa Maria Della Misericordia, Udine, Italy.
    Chiari R; Medical Oncology, Ospedali Riuniti Padova Sud 'Madre Teresa Di Calcutta', Monselice, Italy.
    Gori S; Oncology Unit, IRCCS Ospedale Sacro Cuore Don Calabria, Negrar, Italy.
    Mansueto G; Medical Oncology, F. Spaziani Hospital, Frosinone, Italy.
    Citarella F; Medical Oncology, Campus Bio-Medico University, Rome, Italy.
    Cantini L; Department of Pulmonary Diseases, Erasmus Medical Center, Rotterdam, the Netherlands.; Oncology Clinic, Università Politecnica Delle Marche, Ospedali Riuniti Di Ancona, Ancona, Italy.
    Rijavec E; Medical Oncology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
    Bertolini F; Dipartimento di Oncologia ed Ematologia, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.
    Cappuzzo F; Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
    De Toma A; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
    Friedlaender A; Oncology Department, University Hospital of Geneva, Geneva, Switzerland.
    Metro G; Department of Medical Oncology, Santa Maria della Misericordia Hospital, Azienda Ospedaliera di Perugia, Perugia, Italy.
    Pensieri MV; Department of Biotechnology and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
    Porzio G; Medical Oncology, St. Salvatore Hospital, L'Aquila, Italy.
    Ficorella C; Department of Biotechnology and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.; Medical Oncology, St. Salvatore Hospital, L'Aquila, Italy.
    Pinato DJ; Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, UK.; Department of Translational Medicine, Università del Piemonte Orientale 'A. Avogadro', Novara, Italy.
    Cortellini A; Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, UK.
    Addeo A; Oncology Department, University Hospital of Geneva, Geneva, Switzerland.
    Pokaż więcej
    Źródło:
    Thoracic cancer [Thorac Cancer] 2022 Feb; Vol. 13 (3), pp. 483-488. Date of Electronic Publication: 2021 Dec 22.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    B7-H1 Antigen*/immunology
    Carcinoma, Non-Small-Cell Lung*/pathology
    Lung Neoplasms*/immunology
    Lung Neoplasms*/pathology
    Lung Neoplasms*/therapy
    Humans ; Immunotherapy/methods ; Prognosis ; Retrospective Studies
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
      Wyświetlanie 1-7 z 7

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies